New hope for transplant patients with devastating gut rejection?
Disease control
Terminated
This study tested a drug called apraglutide for patients with a severe complication after a stem cell transplant called graft-versus-host disease (GVHD). It focused on patients whose gut GVHD did not improve with standard steroid treatment. The trial aimed to see if adding apragl…
Phase: PHASE2 • Sponsor: VectivBio AG • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC